Last reviewed · How we verify
Echinacea purpurea alcoholic extract
At a glance
| Generic name | Echinacea purpurea alcoholic extract |
|---|---|
| Sponsor | A. Vogel AG |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Echinacea purpurea alcoholic extract CI brief — competitive landscape report
- Echinacea purpurea alcoholic extract updates RSS · CI watch RSS
- A. Vogel AG portfolio CI